Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2008
03/20/2008US20080069829 Ability to bind to antibodies; diagnosis of allergies
03/20/2008US20080069804 Polynucleotides; RNA; helper cells
03/20/2008US20080069774 Targeting ligand specifically binding to an extracellular component of a cellular system, masking the extracellular component from interacting with a component of the cellular system; thrombotic occlusion and loss of vessel patency at the site of the vascular intervention
03/20/2008US20080069773 Novel Sodium Channel
03/20/2008CA2666819A1 Mammalian oocyte development competency granulosa markers and uses thereof
03/20/2008CA2664318A1 Long lasting drug formulations
03/20/2008CA2662978A1 Hindered ester-based biodegradable linkers for oligonucleotide delivery
03/19/2008EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing
03/19/2008EP1899483A2 Novel targets for the identification of antibiotics that are not susceptible to antibiotic resistance
03/19/2008EP1899471A2 Alkane oxidation by modified hydroxylases
03/19/2008EP1899367A1 Mutant allergen(s)
03/19/2008EP1899363A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease
03/19/2008EP1899362A2 Compositions, kits and methods pertaining to stability modulation of pna oligomer/nucleic acid complexes
03/19/2008EP1898803A2 Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome
03/19/2008EP1815226A4 Device and method for purification of biological materials
03/19/2008EP1778864A4 Capture probe design for efficient hybridisation
03/19/2008EP1636354A4 Erk7 and erk8, novel diagnostic markers for cancer
03/19/2008EP1330650A4 Method and apparatus for reading reporter labeled beads
03/19/2008EP0929564B1 High level expression of proteins
03/19/2008CN101146823A Molecules and chimeric molecules thereof
03/19/2008CN101146818A Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
03/19/2008CN101143884A Nucleic acid automatic extracting instrument
03/19/2008CN100375750C Oligopolynucleotide of inhibiting activity of necrosin in human tumor
03/18/2008US7345220 Aspartate kinase
03/18/2008US7345219 Comprises expression vectors coding nucleotide sequences for transformation and generation of plants with enhanced freeze, disease, drought and salt resistance
03/18/2008US7345216 Expression cassettes for meristem-preferential expression in plants
03/18/2008US7345163 Oligonucleotides can be noncovalently immobilized on solid support in manner that renders them insoluble; consequently, oligonucleotides can remain tightly bound to support while hydrophobic separation functions are selectively removed
03/18/2008US7345161 Detection reagent for shiga toxin family gene of entero-hemorrhagic Escherichia coli
03/18/2008US7345160 Photoprotein capable of binding coelenterazine and molecular oxygen, allows for emission of light at longer wavelengths as result of energy transfer; assay for screening HIV-1 protease inhibitors; microanalysis and drug discovery; kits
03/18/2008US7345159 Massive parallel method for decoding DNA and RNA
03/18/2008US7345158 Cardiac failure, cardiomegaly, myocarditis, cardiomyopathy, arteriosclerosis, arteriosclerosis obliterans, or ischemic heart disease
03/18/2008US7345157 For analyzing the localization or dynamics of a protein in cells, for analyzing a physiologically active substance
03/18/2008US7345156 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
03/18/2008US7345155 Probes, compositions and kits for determining the presence of Mycoplasma genitalium in a test sample
03/18/2008US7345147 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
03/18/2008US7345146 PRO1271 Polypeptides
03/18/2008US7345143 Plastid transit peptides
03/18/2008US7345027 Controlling gene expression using RNA preferential for endothelial growth factor genes and transmembrane tyrosine kinases; antiproliferative agents
03/18/2008US7345025 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
03/18/2008US7344888 Nucleotide sequences coding viral promoter sequences for use in detection of viral infection in plants; regulatory elements for expression of heterologous genes in cells
03/18/2008US7344886 Expression vector comprising neomycin phosphotransferase coding sequences for use as reporter gene system in identification of transgenic cells
03/18/2008US7344882 nucleotide sequences that code human transient receptor potential channel polypeptides or fragments; genetic vectors, host cells, antibodies, and recombinant and synthetic methods for producing polypeptides; drug screening; medical diagnosis
03/18/2008US7344880 Nucleotide sequences coding polypeptide for use in the treatment of immunological disorders
03/18/2008US7344879 Peptide for use in the treatment of cell proliferation disorders
03/18/2008US7344870 3-phosphoinositide-dependent protein kinase
03/18/2008US7344869 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and Streptomyces hosts capable of improved clavulanic acid production
03/18/2008US7344865 Nucleotides; nucleotide sequences; DNA; RNA; templates; primers/genetic/; polymerases; fluorescence; chain extension; bleaching; use to sequence nucleic acids in microfluidic devices using particle arrays
03/18/2008US7344863 Methods for producing polypeptides through enhanced synthesis of encoding nucleic acid molecules
03/18/2008US7344860 Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v
03/18/2008US7344857 Comprises nucleotide sequences coding transcription factor for use as regulatory tools in nervous system development
03/18/2008US7344855 Transforming corynebacterium with expression vector comprising nucleotide sequences coding antisense sequences which reduce expression of cytochrome oxidase and select for accumulation of riboflavin
03/18/2008US7344844 Can be used for the treatment of diabetes or for delaying the onset of diabetes
03/18/2008US7344841 Real-time monitoring of nucleic acid target-identifying signals
03/18/2008US7344838 Gene encoding brain specific membrane protein
03/18/2008US7344834 Using cyclic replication to propagate preferential nucleotide sequences; sequence determination
03/18/2008US7344719 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
03/18/2008CA2476286C Method of recovering micromaterial and device
03/18/2008CA2383554C Methods for the detection, analysis and isolation of nascent proteins
03/18/2008CA2278313C Fluorescent cyanine dyes
03/18/2008CA2243829C Method and device for the simultaneous isolation of genomic dna and high-purity total rna
03/18/2008CA2181073C Tissue-specific enhancer active in prostate
03/13/2008WO2008031004A2 Binding of proanthocyanidins with bacteria and bacterial components
03/13/2008WO2008030122A1 Biomarkers
03/13/2008WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action
03/13/2008WO2008028405A1 Neukinase, a downstream protein of neuregulin
03/13/2008WO2007136758A3 Sirna inhibition of p13k p85, p110, and akt2 and methods of use
03/13/2008WO2007129114A3 Aptamers directed to recombinant muc1
03/13/2008WO2007112753A3 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
03/13/2008WO2007092314A3 Esterases and related nucleic acids and methods
03/13/2008US20080066201 Nucleic acid molecules and other molecules associated with plants
03/13/2008US20080066200 Transgenic plant which serves as bioreactor for expression of humanized glycoproteins with reduced fucose and xylose residues
03/13/2008US20080066199 Using expressed sequence tags as gene targeting tool in transformation and generation of transgenic crop plants
03/13/2008US20080064867 Process for the synthesis of oligonucleotides
03/13/2008US20080064866 Plasmid for efficient transformation and generation of disease, insect and herbicide resistant plants
03/13/2008US20080064865 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders
03/13/2008US20080064864 Expression vector comprising nucleotide sequences coding carbohydrate modifiying enzyme for use in enhancing quality of foodstuffs and baked goods
03/13/2008US20080064863 DNA containing poly(ethylene oxide)-modified oligo- or poly-nucleotide; gene therapy
03/13/2008US20080064862 Recombinant chicken comprising vector which express shell protein in oviducts; enhancing egg hardness
03/13/2008US20080064857 Immunoglobulin for use in diagnosis, prevention and treatment of metabolic disorders of pancreas
03/13/2008US20080064764 Isolated nucleic acids; antibody for selective binding; biodrug treating osteoporosis, osteoblast, bone disorders, osteocalcin mediated disorder
03/13/2008US20080064652 Without inducing hypertriglyceridemia; injecting a therapeutic apoE nucleic acid that expresses a naturally-occurring apoE protein, associated with a liposome directly into the liver; the nucleic acid is a recombinant adeno-associated vector, a lentiviral, herpes viral, or retroviral vector
03/13/2008US20080064651 A 21-base antisense oligonucleotide which inhibits gene expression of testosterone-repressed prostate message-2 by tumor cells; prostate and renal cell cancer; enhanced chemosensitivity, hormone and radiation sensitivities
03/13/2008US20080064650 Therapeutic uses of inhibitors of RTP801L
03/13/2008US20080064648 Methods and Compositions Relating to Lipid Accumulation
03/13/2008US20080064647 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active
03/13/2008US20080064646 Lactobacillus Fermentum N-Desoxyribosyl Transferases and the Use Thereof for Enzymatic Synthesis of 2', 3' - Didesoxynucleosides and 2',3'- Didehydro-2',3'- Didesoxynucleosides
03/13/2008US20080064639 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
03/13/2008US20080064631 T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease
03/13/2008US20080064630 Prolonged circulation time; combined with such as human growth hormone or fragments; nucleic acid constructs, vectors, host cells; culturing and harvesting
03/13/2008US20080064107 Use of multiple transformation enhancer sequences to improve plant transformation efficiency
03/13/2008US20080064097 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
03/13/2008US20080064091 Cassette for Nucleic Acid Expression in Plants
03/13/2008US20080064084 Method For Producing Recombinant Trypsin
03/13/2008US20080064083 Expression vector comprising bacterial nucleotide sequences for use in diagnosis, prevention and treatment of microorganismal infection
03/13/2008US20080064079 Mutant trypsin; protein engineering and sequencing
03/13/2008US20080064069 Protein comprising uridine diphosphate-glucose 4,6-dehydratase, uridine diphosphate-4-keto-6-deoxyglucose 3,5-epimerase and uridine diphosphate-4-keto-rhamnose 4-keto-reductase for use in glycoengineering of polypeptides
03/13/2008US20080064067 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins
03/13/2008US20080064064 Mannanases
03/13/2008US20080064063 Compositions and methods for producing steviol and steviol glycosides
03/13/2008US20080064050 Applications of the binding interaction of proanthocyanidins with bacteria and bacterial components